Skip to main content
SpringerLink
Log in

Gene rearrangements in malignant lymphomas

  • Chapter
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems

Part of the book series: Cancer Treatment and Research ((CTAR,volume 66))

Abstract

Diagnosis and classification of malignant lymphomas is one of the most difficult and challenging problems encountered by pathologists today. Techniques for molecular genetic analysis have added an entirely new dimension to our understanding of the biology of the normal immune response. New knowledge of the mechanisms of DNA rearrangement in non-neoplastic T- and B-lymphoid cells has been exploited to provide information useful in the diagnosis and management of patients with lymphoid malignancies. The molecular techniques used to elucidate the rearrangement of normal antigen receptor genes have now been applied to the analysis of a large number of hyperplastic and malignant lymphoid proliferations, and the clinical utility of gene rearrangement studies in the malignant lymphomas has become well established. Gene rearrangement studies may yield information that is useful in establishing a definitive diagnosis of malignancy, in identifying the lineage of an immunophenotypically unclassifiable malignant population, or in providing data that are of value in predicting the clinical course, prognosis, or therapeutic response of an individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Leder P, Max EE, Seidman JG: The organization of immunoglobulin genes and the origin of their diversity. In M Fougerlan, J Dausset, eds. Immunology 80. New York: Academic Press, 1980, pp 34–50.

    Google Scholar 

  2. Tonegawa S: Somatic generation of antibody diversity. Nature 302:575–581, 1983.

    Article  PubMed  CAS  Google Scholar 

  3. Boehm T, Rabbitts TH: A chromosomal basis of lymphoid malignancy in man. Eur J Biochem 185:1–17, 1989.

    Article  PubMed  CAS  Google Scholar 

  4. Hood L, Kronenberg J, Hunkapillar T: T-cell receptors and the immunoglobulin supergene family. Cell 40:225–229, 1985.

    Article  PubMed  CAS  Google Scholar 

  5. Diamond D, Tanigawa G, Heilig J, et al.: Unusual features of the organization and diversity of T cell receptor chain genes. Nature 316:828–832, 1985.

    Article  PubMed  Google Scholar 

  6. Toyanaga B, Yoshikai Y, Vadaszy V, et al.: Organization and sequences of the diversity, joining and constant region genes of the T-cell receptor β chain. Proc Natl Acad Sci USA 82:8624–8628, 1985.

    Article  Google Scholar 

  7. Hayday AC, Saito H, Gillies SD, et al.: Structure, organization and somatic rearrangement of T-cell gamma genes. Cell 40:259–269, 1985.

    Article  PubMed  CAS  Google Scholar 

  8. Sklar JL, Weiss LM, Cleary ML: Diagnostic molecular biology of non-Hodgkin’s lymphomas. In CW Berard, RF Dorfman, N Kaufman, eds. Malignant Lymphoma. Baltimore: Williams and Wilkins, 1987, pp 204–224.

    Google Scholar 

  9. Van Dongen JJM, Wolvers-Tettero ILM: Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lympho-proliferative diseases and related disorders. Clin Chim Acta 198:93–174, 1991.

    Article  PubMed  Google Scholar 

  10. Yancopoulos GD, Alt FW: Regulation of the assembly and expression of variable-region genes. Ann Rev Immunol 4:339–68, 1986.

    Article  CAS  Google Scholar 

  11. Griesser H, Tkachuk D, Reis MD, et al.: Gene rearrangements and translocations in lymphoproliferative diseases. Blood 73:1402–1415, 1989.

    PubMed  CAS  Google Scholar 

  12. Korsmeyer SJ, Hieter PA, Ravetch JV, et al.: Developmental hierarchy of immunoglobulin gene rearrangements in human leukemic pre-B-cells. Proc Natl Acad Sci USA 78:7096–7100, 1981.

    Article  PubMed  CAS  Google Scholar 

  13. Korsmeyer SJ, Hieter PA, Ravetch JV, et al.: Normal human B cells display ordered light-chain rearrangements and deletions. J Exp Med 156:975–980, 1982.

    Article  PubMed  CAS  Google Scholar 

  14. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503–517, 1975.

    Article  PubMed  CAS  Google Scholar 

  15. Williams ME, Innes DJ Jr, Borowitz MJ, et al.: Immunoglobulin and T cell receptor gene rearrangements in human lymphoma and leukemia. Blood 69:79–86, 1987.

    PubMed  CAS  Google Scholar 

  16. Story CJ, Turner DR, Morley AA, et al.: Diagnostic use of immunoglobulin and T-cell receptor gene rearrangements in lymphoproliferative disease. Aust NZ J Med 17:1–8, 1987.

    Article  CAS  Google Scholar 

  17. Hodges E, Stacey GN, Howell WM, et al.: Clonality of T cell and phenotypically undefined lymphoid neoplasms: the value of genoptypic analyses. J Clin Pathol 43:548–553, 1990.

    Article  PubMed  CAS  Google Scholar 

  18. Feller AC, Griesser H: DNA gene rearrangement studies in Hodgkin’s disease and related lymphomas: a contribution to their cellular origin. Rec Results Cancer Res 117:27–34, 1989.

    Article  CAS  Google Scholar 

  19. Gledhill S, Krajewski AS, Dewar AE, et al.: Analysis of T-cell receptor and immunoglobulin gene rearrangements in the diagnosis of Hodgkin’s and non-Hodgkin’s lymphoma. J Pathol 161:246–254, 1990.

    Article  Google Scholar 

  20. Chen Y-T, Godwin TA, Mouradian JA: Immunohistochemistry and gene rearrangement studies in the diagnosis of malignant lymphomas: a comparison of 152 cases. Hum Pathol 22:1249–1257, 1991.

    Article  PubMed  CAS  Google Scholar 

  21. Wu AM, Winberg CD, Sheibani K, et al.: Genotype and phenotype: a practical approach to the immunogenetic analysis of lymphoproliferative disorders. Hum Pathol 21:1132–1141, 1990.

    Article  PubMed  CAS  Google Scholar 

  22. Kamaat D, Laszewski MJ, Kemp JD, et al.: The diagnostic utility of immunophenotyping and immunogenotyping in the pathologic evaluation of lymphoid proliferations. Mod Pathol 3:105–112, 1990.

    Google Scholar 

  23. Henni T, Gaulard P, Divine M, et al.: Comparison of genetic probe with immunophenotypic analysis in lymphoproliferative disorders: a study of 87 cases. Blood 72:1937–1943, 1988.

    PubMed  CAS  Google Scholar 

  24. Sun T, Eisenberg A, Benn P, et al.: Comparison of phenotyping and genotyping of lymphoid neoplasms. J Clin Lab Anal 3:156–162, 1988.

    Article  Google Scholar 

  25. Rudders RA, Dhillon S, Krontiris TG: Clonal analysis of untreated non-Hodgkin’s lymphoma utilizing immunoglobulin gene rearrangement and immunophenotype. Cancer Res 48: 6272–6277, 1988.

    PubMed  CAS  Google Scholar 

  26. Cossman J, Zehnbauer B, Garrett CT, et al.: Gene rearrangements in the diagnosis of lymphoma/leukemia. Am J Clin Pathol 95:347–354, 1991.

    PubMed  CAS  Google Scholar 

  27. Ramsay AD, Smith WJ, Isaacson PG: T-cell-rich B-cell lymphoma. Am J Surg Pathol 12:433–443, 1988.

    Article  PubMed  CAS  Google Scholar 

  28. Osborne BM, Butler JJ, Pugh WC: The value of immunophenotyping on paraffin sections in the identification of T-cell rich B-cell large cell lymphomas: lineage confirmed by JH rearrangement. Am J Surg Pathol 14:933–938, 1990.

    Article  PubMed  CAS  Google Scholar 

  29. Fishleder A, Tubbs R, Hessie B, et al.: Uniform detection of immunoglobulin gene rearrangement in benign lymphoepithelial lesions. N Engl J Med 316:1118–1121, 1987.

    Article  PubMed  CAS  Google Scholar 

  30. Falzon M, Isaacson PG: The natural history of benign lymphoepithelial lesion of the salivary gland in which there is a monoclonal population of B cells: a report of two cases. Am J Surg Pathol 15:59–65, 1991.

    Article  PubMed  CAS  Google Scholar 

  31. Knowles DM, Athan E, Ubriaco A, et al.: Extranodal noncutaneous lymphoid hyperplasias represent a continuous spectrum of B-cell neoplasia: demonstration by molecular genetic analysis. Blood 73:1635–1645, 1989.

    PubMed  CAS  Google Scholar 

  32. Hammer E, Sangueza O, Suwanjindar P, et al.: Immunophenotypic and genotypic analysis in cutaneous lymphoid hyperplasias. J Am Acad Dermatol 28:426–433, 1993.

    Article  PubMed  CAS  Google Scholar 

  33. Cleary ML, Warnke R, Sklar J: Monoclonality of lymphoproliferative lesions in cardiac transplant patients: clonal analysis based on immunoglobulin gene rearrangements. N Engl J Med 310:477–82, 1984.

    Article  PubMed  CAS  Google Scholar 

  34. Wood GS, Ngan BY, Tung R, et al.: Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia. Am J Pathol 135:13–19, 1989.

    PubMed  CAS  Google Scholar 

  35. Hammer E, Suwanjindar P, Braziel RM: Molecular analysis of CD3 (+) and CD3 (-) peripheral T-cell lymphomas. Mod Pathol 5:78A, 1992.

    Google Scholar 

  36. Weiss LM, Wood GS, Trela M, et al.: Clonal T-cell populations in lymphomatoid papulosis: evidence of a lymphoproliferative origin for a clinically benign disease. N Engl J Med 315:475–479, 1986.

    Article  PubMed  CAS  Google Scholar 

  37. Kadin ME, Vonderheid ED, Sako D, et al.: Clonal composition of T cells in lymphomatoid papulosis. Am J Pathol 126:13–17, 1987.

    PubMed  CAS  Google Scholar 

  38. Zelickson BD, Peters MS, Muller SA, et al.: T-cell receptor gene rearrangement analysis: cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 25:787–796, 1991.

    Article  PubMed  CAS  Google Scholar 

  39. Weiss LM, Picker LJ, Grogan TM, et al.: Absence of clonal beta and gamma T-cell receptor gene rearrangements in a subset of peripheral T-cell lymphomas. Am J Pathol 130:436–442, 1988.

    PubMed  CAS  Google Scholar 

  40. Pittaluga S, Uppenkamp M, Cossman J: Development of T3/T cell receptor gene expression in human pre-T neoplasms. Blood 69:1062–1067, 1987.

    PubMed  CAS  Google Scholar 

  41. Qazi R, Aisenberg AC, Long JC: The natural history of nodular lymphoma. Cancer 37:1923–1927, 1988.

    Article  Google Scholar 

  42. Horning SJ, Rosenberg SA: The natural history of initially untreated low-grade non-Hodgkin’s lymphomas. N Engl J Med 311:1471–1476, 1984.

    Article  PubMed  CAS  Google Scholar 

  43. Rowley JD: Recurring chromosome abnormalities in leukemia and lymphoma. Semin Hematol 27:122–136, 1990.

    PubMed  CAS  Google Scholar 

  44. Taub R, Kirsch L, Morton C, et al.: Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt’s lymphoma and mouse plasmacytoma cells. Proc Natl Acad Sci USA 79:7837–7841, 1982.

    Article  PubMed  CAS  Google Scholar 

  45. Cesarman E, Dalla-Favera R, Bentley D, et al.: Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science 238:1272–1275, 1987.

    Article  PubMed  CAS  Google Scholar 

  46. Adams JM, Gerondakis S, Webb E, et al.: Cellular myc oncogene is altered by chromosome translocation to an immunoglobulin locus in murine plasmacytomas and is rearranged similarly in human Burkitt lymphomas. Proc Natl Acad Sci USA 80:1982–1986, 1983.

    Article  PubMed  CAS  Google Scholar 

  47. Ar-Rushdi A, Nishikura K, Erikson J, et al.: Differential expression of the translocated and the untranslocated c-myc oncogene in Burkitt lymphoma. Science 222:390–393, 1983.

    Article  PubMed  CAS  Google Scholar 

  48. Bernard O, Cory S, Gerondakis S, et al.: Sequence of the murine and human cellular myc oncogenes and two modes of myc transcription resulting from chromosome translocation in B lymphoid tumours. EMBO J 2:2375–2383, 1983.

    PubMed  CAS  Google Scholar 

  49. Adams JM, Harris AW, Pinkert CA, et al.: The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318:533–538, 1985.

    Article  PubMed  CAS  Google Scholar 

  50. Wiman KG, Clarkson B, Hayday AC, et al.: Activation of a translocated c-myc gene: role of structural alteration in the upstream region. Proc Natl Acad Sci USA 81:6798–6802, 1984.

    Article  PubMed  CAS  Google Scholar 

  51. Rabbitts TH, Foster A, Hamlyn P, et al.: Effect of somatic mutation within translocated c-myc genes in Burkitt’s lymphoma. Nature 309:592–597, 1984.

    Article  PubMed  CAS  Google Scholar 

  52. Giallongo A, Appella E, Ricciardi R, et al.: Identification of the c-myc oncogene product in normal and malignant B-celis. Science 222:430–432, 1983.

    Article  PubMed  CAS  Google Scholar 

  53. Fukuhara S, Rowley JD, Varrakojis D, et al.: Chromosome abnormalities in poorly differentiated lymphocytic lymphoma. Cancer Res 39:3119–3131, 1979.

    PubMed  CAS  Google Scholar 

  54. McDonnell TJ, Korsmeyer SJ: Progression from lymphoid hyperplasia to high-grade malignant lymphoma in mice transgenic for the t(14;18). Nature 349:254–56, 1991.

    Article  PubMed  CAS  Google Scholar 

  55. Strasser A, Harris AW, Bath ML, et al.: Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature 348:331–33, 1990.

    Article  PubMed  CAS  Google Scholar 

  56. Tsujimoto Y, Jaffe E, Cossman J, et al.: Clustering of breakpoints on chromosome 11 in human B-cell neoplasms with the t(ll;14) chromosome translocation. Nature 315:340–343, 1985.

    Article  PubMed  CAS  Google Scholar 

  57. Withers DA, Harvey RC, Faust JB, et al.: Melnyk O, Carey K, Meeker TC: Characterization of a candidate bcl-1 gene. Mol Cell Biol 11:4846–4853, 1991.

    PubMed  CAS  Google Scholar 

  58. Motokura T, Bloom T, Kim HG, et al.: A novel cyclin encoded by a bcl-l-linked candidate oncogene. Nature 350:512–515, 1991.

    Article  PubMed  CAS  Google Scholar 

  59. Faust JB, Meeker TC: Amplification and expression of the bcl-1 gene in human solid tumor cell lines. Cancer Res 52:2460–2463, 1992.

    PubMed  CAS  Google Scholar 

  60. Raffeld M, Jaffe ES: Bcl-1, t(ll;14), and mantle cell-derived lymphomas. Blood 78:259–263, 1991.

    PubMed  CAS  Google Scholar 

  61. Rimokh R, Berger F, Cornillet P, et al.: Break in the Bcll locus is closely associated with intermediate lymphocytic lymphoma subtype. Genes Chrom Cancer 2:223–226, 1990.

    Article  PubMed  CAS  Google Scholar 

  62. Williams ME, Westermann CD, Swerdlow SH: Genotypic characterization of centrocytic lymphoma: frequent rearrangement of the chromosome 11 bcl-1 locus. Blood 76:1387–1391, 1990.

    PubMed  CAS  Google Scholar 

  63. Medeiros LJ, Van Krieken JH, Jaffe ES, et al.: Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation. Blood 76:2086–2090, 1990.

    PubMed  CAS  Google Scholar 

  64. Williams ME, Meeker TC, Swerdlow SH: Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes. Blood 78:493–498, 1991.

    PubMed  CAS  Google Scholar 

  65. Yunis JJ, Frizzera G, Oken MM, et al.: Multiple recurrent genomic defects in follicular lymphoma. N Engl J Med 316:79–84, 1987.

    Article  PubMed  CAS  Google Scholar 

  66. Tsujimoto Y, Finger LR, Yunis J, et al.: Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation. Science 226:1097–1099, 1984.

    Article  PubMed  CAS  Google Scholar 

  67. Tsujimoto Y, Gorham J, Cossman J, et al.: The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining. Science 229:1390–1393, 1985.

    Article  PubMed  CAS  Google Scholar 

  68. Bakhshi A, Jensen JP, Goldman P, et al.: Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 41:889–906, 1985.

    Article  Google Scholar 

  69. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 82:7439–7443, 1985.

    Article  PubMed  CAS  Google Scholar 

  70. Cleary ML, Smith SD, Sklar J: Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation. Cell 47:19–28, 1986.

    Article  PubMed  CAS  Google Scholar 

  71. Lipford E, Wright JJ, Urba W, et al.: Refinement of lymphoma cytogenetics by the chromosome 18q21 major breakpoint region. Blood 70:1816–1823, 1987.

    PubMed  CAS  Google Scholar 

  72. Cleary ML, Galili N, Sklar J: Detection of a second t(14;18) breakpoint cluster region in human follicular lymphomas. J Exp Med 164:315–320, 1985.

    Article  Google Scholar 

  73. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214–5218, 1986.

    Article  PubMed  CAS  Google Scholar 

  74. Seto M, Jaeger J, Hockett RD, et al.: Alternative promoters and exons, somatic mutation and transcriptional deregulation of the Bcl-2-Ig fusion gene in lymphoma. EMBO J 7: 123–131, 1988.

    PubMed  CAS  Google Scholar 

  75. Graninger WB, Seto M, Boutain B, et al.: Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells. J Clin Invest 80:1512–1515, 1987.

    Article  PubMed  CAS  Google Scholar 

  76. Hua C, Zorn S, Jensen JP, et al.: Consequences of the t(14;18) chromosomal translocation in follicular lymphoma: deregulated expression of a chimeric and mutated BCL-2 gene. Oncogene Res 2:263–275, 1988.

    PubMed  CAS  Google Scholar 

  77. Cleary ML, Ngan BY, Chen-Levy Z, et al.: The Bcl-2 proto-oncogenic protein associated with t(14;18) translocations: biochemical properties and expression in non-Hodgkin’s lymphomas. Proc Natl Acad Sci USA 86:2771–2774, 1989.

    Article  Google Scholar 

  78. Nunez G, Seto M, Seremetis S, et al.: Growth and tumor-promoting effects of deregulated bcl-2 in human B-lymphoblastoid cells. Proc Natl Acad Sci USA 86:4589–92, 1989.

    Article  PubMed  CAS  Google Scholar 

  79. Nunez G, London L, Hockenbery D, et al.: Deregulated bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. J Immunol 144:3602–3610, 1990.

    PubMed  CAS  Google Scholar 

  80. McDonnell TJ, Nunez G, Platt FM, et al.: Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population. Mol Cell Biol 10:1901–1907, 1990.

    PubMed  CAS  Google Scholar 

  81. Hockenbery D, Nunez G, Milliman C, et al.: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334–336, 1990.

    Article  PubMed  CAS  Google Scholar 

  82. Crescenzi M, Seto M, Herzig GP, et al.: Thermostable DNA polymerase chain amplification of t(14;18) chromosome breakpoints and detection of minimal residual disease. Proc Natl Acad Sci USA 85:4869–4873, 1988.

    Article  PubMed  CAS  Google Scholar 

  83. Gribben J, Freedman A, Woo SD, et al.: All advanced stage non-Hodgkin’s lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood 78:3275–3280, 1991.

    PubMed  CAS  Google Scholar 

  84. Gribben JG, Freedman AS, Neuberg D, et al.: Immunologic purging of polymerase chain reaction detectable lymphoma cells results in increased disease free survival following autologous bone marrow transplantation for B-cell non-Hodgkin’s lymphomas. N Engl J Med 325:1525–1533, 1991.

    Article  PubMed  CAS  Google Scholar 

  85. Limpens J, de Jong D, van Krieken JHJM, et al.: Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia. Oncogene 6:2271–2276, 1991.

    PubMed  CAS  Google Scholar 

  86. Guinee D, von Borstel R, Zutter M, et al.: JH/Bcl-2 translocation and Bcl-2 protein expression in hyperplastic tonsils. Mod Pathol 5:78A, 1992.

    Google Scholar 

  87. Braziel RM, Grogan T, Berman M, et al.: Bcl-2/JH translocation in follicular lymphoid hyperplasia. Mod Pathol 4:68A, 1991.

    Google Scholar 

  88. Stetler-Stevenson M, Crush-Stanton S, Cossman J: Involvement of the bcl-2 gene in Hodgkin’s disease. J Natl Cancer Inst 82:855–858, 1990.

    Article  PubMed  CAS  Google Scholar 

  89. Louie DC, Kant JA, Brooks JJ, et al.: Absence of t(14;18) major and minor breakpoints and of Bcl-2 protein overproduction in Reed-Sternberg cells of Hodgkin’s disease. Am J Pathol 139:1231–1237, 1991.

    PubMed  CAS  Google Scholar 

  90. Said JW, Sassoon AF, Shintaku IP, et al.: Polymerase chain reaction for bcl-2 in diagnostic lymph node biopsies. Mod Pathol 3:659–663, 1990.

    PubMed  CAS  Google Scholar 

  91. Said JW, Sassoon AF, Shintaku IP, et al.: Absence of bcl-2 major breakpoint region and JH gene rearrangement in lymphocyte predominance Hodgkin’s disease. Am J Pathol 138:261–264, 1991.

    PubMed  CAS  Google Scholar 

  92. Zutter M, Hockenbery D, Silverman GA, et al.: Immunolocalization of the Bcl-2 protein within hematopoietic neoplasms. Blood 78:1062–1068, 1991.

    PubMed  CAS  Google Scholar 

  93. Sundeen J, Lipford E, Uppenkamp M, et al.: Cossman J: Rearranged antigen receptor genes in Hodgkin’s disease. Blood 70:96–103, 1987.

    PubMed  CAS  Google Scholar 

  94. Brinker MGL, Poppema S, Buys CHCM, et al.: Clonal immunoglobulin gene rearrangements in tissues involved by Hodgkin’s disease. Blood 70:186–191, 1987.

    PubMed  CAS  Google Scholar 

  95. Weiss LM, Strickler JG, Hu E, et al.: Immunoglobulin gene rearrangements in Hodgkin’s disease. Hum Pathol 17:1009–1014, 1986.

    Article  PubMed  CAS  Google Scholar 

  96. Griesser H, Feller AC, Mak TW, et al.: Clonal rearrangements of T-cell receptor and immunoglobulin genes and immunophenotypic antigen expression in different subclasses of Hodgkin’s disease. Int J Cancer 40:157–160, 1987.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Rita M. Braziel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allan R. Sacker
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health Sciences University, USA

    Bruce W. Dana (Clinical Associate Professor of Medicine, Member) (Clinical Associate Professor of Medicine, Member)

  2. The Hematology Clinic Portland, Oregon, USA

    Bruce W. Dana (Clinical Associate Professor of Medicine, Member) (Clinical Associate Professor of Medicine, Member)

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media New York

About this chapter

Cite this chapter

Braziel, R.M., Sacker, A.R. (1993). Gene rearrangements in malignant lymphomas. In: Dana, B.W. (eds) Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems. Cancer Treatment and Research, vol 66. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3084-8_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3084-8_10

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6347-7

  • Online ISBN: 978-1-4615-3084-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation